Revenue Projection

No one can predict the future, but with the right research and analysis, you can understand the different market scenarios you may face. DeciBio takes a data-driven approach, considering customer demand and preference, product profile, competitive dynamics, regulation, and other market factors to inform your potential revenue scenarios.

Our Experts

David Cavanaugh

David Cavanaugh

Stephane Budel

Miguel Edwards

Schedule a Call

Related Client Results

All Client Results

AI Patient Recruitment Go-to-Market Strategy

A healthcare technology startup wanted to conduct an assessment of potential go-to-market strategies for their AI analytical patient recruitment tool

Voice-of-Customer Research

Go-to-Market Strategy

Competitive Analysis

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Life Science Tools & Manufacturing

RWD Biobank Offering Go-to-Market Strategy

The ventures arm of a top-20 U.S. health system sought support developing a go-to-market strategy for RWD-augmented biobank offerings

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing

A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution

Customer Segmentation

Voice-of-Customer Research

Market Landscaping and Sizing

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

Competitive Analysis

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help